|
Patients with min. Follow-up (12 month), n (%)
|
55 (67.9)
| |
20 (62.5)
|
|
Follow-up interval in month
| | | |
|
• Mean (sd)
|
53 (26)
| |
62 (40)
|
|
• Min-Max
|
12–119
| |
12–112
|
|
Complications
|
|
Patients with major complication, n (%)
|
20 (36.4)
|
0.91
|
7 (35.0)
|
|
Recurrence of infection, n (%)
|
12 (21.8)
|
0.25
|
7 (35.0)
|
|
(Re-) Amputation, n (%)
|
6 (10.9)
|
0.31
|
4 (20.0)
|
|
MKA Loosening, n (%)
|
8 (14.5)
|
n/a
|
–
|
|
MKA Implant failure, n (%)
|
1 (1.8)
|
n/a
|
–
|
|
Peri-implant fracture, n (%)
|
4 (7.3)
|
n/a
|
–
|
|
Patients with functional follow up, n (%)
|
48 (59.3%)
| |
10 (31.3%)
|
|
Functional follow-up examination
|
|
LEFSa, mean (sd)
|
28 (13.7)
|
0.181
|
37 (26.4)
|
|
Physical SF-12, mean (PCS) (sd)
|
30 (9.1)
|
0.080
|
36 (14.5)
|
|
Mental SF-12, mean (MCS) (sd)
|
46 (11.2)
|
0.755
|
47 (12.0)
|
